Check out your Company Bowl for anonymous work chats.
We are proud to announce that Peter Ronco has been named Emmes’ new Chief Executive Officer. As a seasoned and innovative life science leader, we are confident that Peter will help advance Emmes’ position as a pioneer in clinical research. Please join us in welcoming him to the Emmes team.
Emmes Appoints Peter Ronco as Chief Executive Officer
We are proud to announce that we have acquired VaxTrials, a specialized Clinical Research Organization providing innovative solutions in managing and monitoring vaccine clinical trial activities across Latin America. As a complementary match for Emmes, VaxTRIALS CEO, Jose Jimeno describes, “Both our companies have built enduring customer relationships and a legacy of service in vaccine and infectious disease research. I am proud that we have made both people and cultural development a priority, including hiring and developing employees who care deeply about making a difference in public health.”
Emmes Acquires VaxTRIALS